The pQTL analysis indicated that increased plasma NMB levels were associated with a heightened risk of AD (OR = 1.18, p = 3.29 × 10^-8), a conclusion further corroborated by SMR analysis. This evidence concerns the gene NMB and Alzheimer disease.